List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 24 studies with search of: Von Hippel-Lindau Disease (VHL)
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Unknown † Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease
Conditions: Von Hippel-Lindau Disease;   Hemangioblastoma;   Renal Cell Carcinoma;   Pheochromocytoma;   Pancreatic Neuroendocrine Tumor
Intervention: Other: 89Zr bevacizumab PET scan
2 Completed
Has Results 		17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease
Conditions: Hippel-Lindau Disease;   Kidney Cancer
Interventions: Drug: 17 allylamino-17-demethoxygeldanamycin;   Drug: 18 FDG (Fludeoxyglucose 18F);   Drug: [15-O] H2O;   Drug: EPL diluent
3 Completed Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584
Conditions: Von Hippel-Lindau Disease;   Central Nervous System Capillary Hemangioblastoma;   Retinal Capillary Hemangioblastoma
Intervention: Drug: PTK787/ZK 222584
4 Terminated
Has Results 		Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow
Conditions: Von Hippel-Lindau Syndrome;   Renal Cell Carcinoma;   Hemangioblastoma
Intervention: Drug: SU011248
5 Active, not recruiting Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
Conditions: Hemangioblastomas;   Von Hippel Lindau Disease
Intervention: Drug: Avastin
6 Terminated
Has Results 		Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Sunitinib Malate
7 Recruiting Pazopanib in Von Hippel-Lindau (VHL) Syndrome
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Pazopanib
8 Completed Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Ranibizumab
9 Completed EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Hippel-Lindau Disease
Intervention: Drug: EYE001
10 Completed Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome
Conditions: Kidney Cancer;   Von Hippel-Lindau Syndrome
Intervention: Genetic: mutation analysis
11 Completed Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors
Conditions: Deafness;   Kidney Diseases;   Kidney Neoplasms;   Neoplasms;   Retinal Diseases
Intervention:
12 Recruiting Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease
Condition: Von Hippel-Lindau Disease
Intervention: Drug: Sunitinib
13 Active, not recruiting Von Hippel-Lindau Disease Genetic Epidemiology Study
Condition: Hippel Lindau Disease
Intervention:
14 Active, not recruiting Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
Conditions: Hemangioblastoma;   Hippel Lindau Disease
Intervention:
15 Recruiting Phase II Study of Vandetanib in Individuals With Kidney Cancer
Conditions: Renal Cancer;   Von Hippel Lindau
Intervention: Drug: ZACTIMA (Vandetanib) (ZD6474)
16 Not yet recruiting TKI 258 in Von Hippel-Lindau Syndrome (VHL)
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Dovitinib
17 Recruiting Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease
Condition: Pancreatic Lesions
Intervention:
18 Recruiting Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
Conditions: Hemangioblastoma;   Hereditary Neoplastic Syndrome;   Hippel Lindau Disease;   Neoplasm;   Renal Cell Carcinoma
Intervention:
19 Completed Tumor Angiogenesis in Patients With Endocrine Tumors
Conditions: Adrenocortical Carcinoma;   Head and Neck Cancer;   Islet Cell Tumor;   Multiple Endocrine Neoplasia;   Neoplastic Syndrome;   Neuroblastoma;   Pheochromocytoma;   Von Hippel-Lindau Syndrome
Interventions: Genetic: DNA methylation analysis;   Genetic: in situ hybridization;   Genetic: microarray analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: biopsy
20 Completed Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Biological: aldesleukin;   Biological: incomplete Freund's adjuvant;   Biological: sargramostim;   Biological: von Hippel-Lindau peptide vaccine

Previous Page Studies Shown (1-20) Next Page (21-24)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services